Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer
Wang Ji(Zhejiang University), Shui Wang(Jiangsu Provincial Academy of Environmental Science), Minghui Li(Fudan University), Rui Chen(Nanjing Medical University), Xinyang Wang, Tiansong Xia(Nanjing Medical University), Ge Ma(Nanjing Medical University), Mengdi Liang(Anhui University of Science and Technology)
Cited by 3
Related Papers
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
|International Journal of Biological Sciences|2016|286
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
|Journal of Hematology & Oncology|2019|276
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
|Oncogene|2019|265
MCU Up‐regulation contributes to myocardial ischemia‐reperfusion Injury through calpain/OPA‐1–mediated mitochondrial fusion/mitophagy Inhibition
|Journal of Cellular and Molecular Medicine|2019|138
China’s Soil Pollution Control: Choices and Challenges
|Environmental Science & Technology|2016|122